ALK and anaplastic large cell lymphoma: On subgroup analysis, the ORR was best in ENKTL (63.2%, 12/19), followed by ALK+ALCL (53.8%, 7/13), ALK-ALCL (42.9%, 3/7), and PTCL-NOS (17.9%, 5/28) [23].